CAG
OCUL icon

Crestwood Advisors Group’s Ocular Therapeutix OCUL Stock Holding History

Crestwood Advisors Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,900
Closed -$26K – 354
2017
Q1 		$26K Buy
+2,900
New +$26K ﹤0.01% 340